date,title,source
Oct-17-18,Billionaire Tech Titans Award Millions to Make Scientists Stars,Bloomberg
Oct-17-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Gogo, Jagged Peak Energy, Everbridge, Roku, Corium International, and Ionis Pharmaceuticals  New Research Emphasizes Economic Growth",GlobeNewswire
Oct-22-18,Phase 1b/2 Data of Durvalumab Plus Danvatirsen Presented at European Society for Medical Oncology,PR Newswire
Oct-23-18,Dr. C. Frank Bennett Receives Leslie Gehry Brenner Prize for Innovation in Science,PR Newswire
Oct-24-18,Today's Research Reports on Trending Tickers: Sage Therapeutics and Ionis Pharmaceuticals,ACCESSWIRE
Oct-24-18,Ionis Pharmaceuticals to Hold Third Quarter 2018 Financial Results Webcast,PR Newswire
Oct-31-18,Advances in Ionis' Novel Antisense Technology to be Presented at 2018 Society for Neuroscience Meeting,PR Newswire
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-06-18,"Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-06-18,Ionis Pharmaceuticals: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Ionis Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-07-18,Edited Transcript of IONS earnings conference call or presentation 6-Nov-18 4:30pm GMT,Thomson Reuters StreetEvents
Nov-07-18,Ionis Pharmaceuticals to Present at Upcoming Investor Conferences,PR Newswire
Nov-08-18,"Recent Analysis Shows Automatic Data Processing, GTx, Ionis Pharmaceuticals, TriNet Group, Ternium S.A, and UNIVERSAL INSURANCE HOLDINGS INC Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-08-18,Akcea and Ionis Announce Late-Breaking Presentation of Data From AKCEA-APO(a)-LRx at the American Heart Association Scientific Sessions,GlobeNewswire
Nov-09-18,Ionis Pharmaceuticals to Host Investor Day,PR Newswire
Nov-12-18,5 Pharma Stocks to Stay Away From,InvestorPlace
Nov-12-18,Ionis Pharmaceuticals Collects Royalties -- and Spends It All,Motley Fool
Nov-12-18,Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions,GlobeNewswire
Nov-13-18,Ionis Pharmaceuticals to Present at Jefferies 2018 London Healthcare Conference,PR Newswire
Nov-14-18,Stocks Not in a Bouncy Mood Yet,Zacks
Nov-19-18,Edited Transcript of IONS earnings conference call or presentation 6-Nov-18 4:30pm GMT,Thomson Reuters StreetEvents
Nov-27-18,First-in-class therapies using advanced antisense chemistries highlighted at 2018 American Society of Hematology Annual Meeting,PR Newswire
Nov-29-18,Why Pfizer Could Lead These Two Biotech Stocks In Tackling Amyloidosis,Investor's Business Daily
Dec-06-18,Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data,GlobeNewswire
Dec-11-18,"Is Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Expensive For A Reason? A Look At The Intrinsic Value",Simply Wall St.
Dec-12-18,"Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate",Zacks
Dec-13-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis",Zacks
Dec-14-18,"Should You Buy Ionis Pharmaceuticals, Inc. (IONS)?",Insider Monkey
